Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA112372
Max Phase: Preclinical
Molecular Formula: C14H19NO6
Molecular Weight: 297.31
Molecule Type: Small molecule
Associated Items:
ID: ALA112372
Max Phase: Preclinical
Molecular Formula: C14H19NO6
Molecular Weight: 297.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)NC1C(Oc2ccccc2)OC(CO)C(O)C1O
Standard InChI: InChI=1S/C14H19NO6/c1-8(17)15-11-13(19)12(18)10(7-16)21-14(11)20-9-5-3-2-4-6-9/h2-6,10-14,16,18-19H,7H2,1H3,(H,15,17)
Standard InChI Key: ZUJDLWWYFIZERS-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 297.31 | Molecular Weight (Monoisotopic): 297.1212 | AlogP: -0.99 | #Rotatable Bonds: 4 |
Polar Surface Area: 108.25 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.23 | CX Basic pKa: | CX LogP: -0.89 | CX LogD: -0.89 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.57 | Np Likeness Score: 1.09 |
1. Chung SJ, Takayama S, Wong CH.. (1998) Acceptor substrate-based selective inhibition of galactosyltransferases., 8 (23): [PMID:9873734] [10.1016/s0960-894x(98)00618-0] |
Source(1):